Efficacy and Safety of Vortioxetine and Duloxetine 60 mg Compared Placebo for the Treatment of Major Depressive Disorder: A Systematic Review and Meta-Analysis

Journals Menu

Follow SCIRP

ISSN Print: 2160-5866
ISSN Online: 2160-5874
www.scirp.org/journal/jbbs
E-mail: jbbs@scirp.org

"Efficacy and Safety of Vortioxetine and Duloxetine 60 mg Compared Placebo for the Treatment of Major Depressive Disorder: A Systematic Review and Meta-Analysis"
written by Masoud Behzadifar, Abouzar Keshavarzi, Abed Tofighian, Mohammad Rastian, Mohammad Zobidi, Ali Akbari Sari,
published by Journal of Behavioral and Brain Science, Vol.5 No.10, 2015

has been cited by the following article(s):

[1]	The efficacy and safety of 10 mg/day vortioxetine compared to placebo for adult major depressive disorder: a meta-analysis
	2019

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top